Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
What hemisphere of the brain is the most dominant?
|
The Left Hemisphere
|
|
What hemisphere is considered to deal with creativity?
|
The Right Hemisphere
|
|
What is the diencephalon of the brain?
|
It is the structure that lies under the cerebrum and contains the thalamus and hypothalamus.
|
|
What is the thalamus responsible for?
|
crude sensation except smell
|
|
What is the hypothalamus for?
|
produces triggering signal hormones for the pituitary gland
|
|
What is hypophysis?
|
A technical term for pituitary.
|
|
What is the pituitary?
|
master gland of the body that regulates multiple functions
|
|
What is the brainstem?
|
(dinosaur brain) that controls basic funcion such as sleep, wake, and response to noxious (harmful, unpleasant, poisonous) stimuli. Also controls temperature and respirations
|
|
What does the cerebellum do?
|
Coordinates fine motor movement
controls voluntary actions gauges distance and speed |
|
Sensory receptors interact with what nerves?
|
the afferent nerves
|
|
Lower motor neurons interact with what neurons?
|
The efferent neurons
|
|
The sympathetic nervous system is located ?
|
between T1 and L2-L3. Provides fight or flight
|
|
The parasympathetic NS is located?
|
between S2-S4 and cranial nerves III, VII, IX, and X
|
|
Signs of ALOC are?
|
Confusion
Drowsiness Lethargy Headache Visual disturbances |
|
Signs of a stroke are?
|
Ataxic (jerky) gait
Muscle weakness Slurred Speech Unilateral loss of motor fxn sudden loss of bowel and/or bladder control sudden lower extremity weakness |
|
Migraine
|
episodic manifested by frontotemperal, throbbing pain often worse behind one eye or ear. Often accompanied by sensitive scalp, anorexia, photophobia, and nausea, with or without vomiting.
|
|
Cluster Headaces
|
Unilateral, culotemperal or oculofrontal headache with boring, excrutiating, and nonthrobbing. Pain may radiate. Usually accompanied by ipsilateral tearing of eye, rhinorrhea, ptosis, and miosis.
|
|
Tension headache
|
Characterized by back and shoulder muslce tenderness and bilateral pain in the base of the skull and on the forehead. Appears to be related to stress.
|
|
Signs of a stroke are?
|
Transcient or prolonged loss of consciousness, lethargy or drowsiness. Difficulty with focusing on tasks. Blurred vission, unilateral numbness of face and extremities, loss of proprioception, dysphasia, aphasia, neglect syndrome, hemiplegia (paralysis), hemiparesis (weakness), hypotonia (dec. muscle tone) or hypertonia (muscles are flexing), hypoglossia.
|
|
Alzheimer's
|
chronic progressive disease of the brain that results in dementia. Characterized by memory loss, judgment, and visuospatial perception loss, as well as personality change
|
|
Parkinson's
|
A debilitating disease affecting motor ability
• Etiology: characterized by tremor, rigidity, akinesia and postural instability. |
|
Alzheimer’s:
|
Development of neurofibrillary tangles and plaques that destroy cerebral tissue, altering mental functioning. Particularly noted in the hippocampus. Accompanying increased vascular degeneration is also noted in
clients with AD |
|
Parkinson's
|
Widespread degeneration of the
substansia nigra leads to decreased levels of Dopamine, a neurotransmitter that governs fine motor movement along with acetycholine (ACh). As the level of Dopamine continues to decline more control is lost. New research that loss of another neurotransmitter, norepinepherine, results in progressive hypotension as well. |
|
Huntington’s Disease:
|
A decrease in gammaaminobutyric
acid (GABA) and ACh, both excitatory neurotransmitters, results in an imbalance with Dopamine. The outcome is jerky, purposeless movements of the hands, face, tongue and legs. Progress is in 3 stages – Stage 1-neurologic or psychological Sx – Stage 2-Increasing dependence – Loss of independence |
|
Alzheimer’s:
|
Formation of beta amyloid plagues
in the precentral gyrus of the frontal brain appears to destroy normal brain function, interfering with reasoning nand memory capacity. Neurofibrillary tangles cover the neurons, interrupting signal transmission across neuronal synapses. Vascular degeneration occurs more rapidly than with normal aging, increasing cerebral atrophy. |
|
• Parkinson’s:
|
• Stoop posture, flexed trunk, wrist slightly dorsiflexed
• Gait-Slow, shuffling, short, unsure steps, difficulty stopping quickly • Motor-bradykinesia, akinesia, pill rolling movement, masklike facies • Speech-Soft, low-pitch voice, dysarthria, echolalia and repetition of sentences |
|
Huntington’s:
|
• Facial jerking side to side or side to center
• Rapid, purposeless tongue movement • Lower arm and hand jerking movements • Uncontrolled knee, leg and/or foot jerking • Hesitant or explosive speech • Poor balance • Bowel and/or bladder incontinence |
|
• Alzheimer’s:
• Early Stage: |
• Forgets names, misplaces items
• Mild memory loss • Short attention span • Subtle personality changes • Cognitive impairment, judgment • Decreased knowledge of current events • Wandering |
|
• Alzheimer’s
• Middle stage: |
• Severe cognitive impairment
• Disorientation to time, place event • Possible depression • Physical Impairment • Loss of ability to care for self • Speech and language deficits • Incontinent • Wandering |
|
• Alzheimer’s
• Late stage: |
• Completely incapacitated
• Total dependence • Motor and verbal skills lost • General and focal neurological deficits |
|
• Potential complications
• Parkinson’s: |
• Major problems with falls as disease progresses.
• Potential for aspiration as motor control deteriorates and swallowing is less controlled |
|
• Potential complications
• Alzheimer’s: |
• Risk for injury due to wandering into traffic
• Potential for falls • Potential for dehydration and malnutrition • Possible injury to self and others • Skin breakdown secondary to incontinence of bowel and bladder |
|
• Nutritional needs
• All: Alzheimer's, Parkinson's, Hunnington's |
As each advances there is a growing risk for
aspiration, dehydration and malnutrition. • Softer, smoother textured foods, such as pureed foods or puddings, may be more easily swallowed with the deterioration of muscle control. Thickened liquids are safer than thin liquids such as water when swallowing is hard to control. It is important to provide calorie dense foods as the volume consumed may decrease over time. |
|
• Parkinson’s
|
• Age of onset is typically between 40-70 with the
peak in the 60’s |
|
Hunningtons
|
• Usual age of onset of symptoms is 35-50.
|
|
• Alzheimer’s:
|
• Usual onset is older than 40, and highest
incidence is after 65. |
|
• Hormone Production:
|
• Assist in BP control by converting angiotensin I to
angiotensin II |
|
• Prostaglandins:
|
• PGE2 and prostacyclin which help regulate glomerular
filtration, renal vascular resistance and renin production |
|
• Bradykinin:
|
• Dilates afferent arteriole and increases capillary
membrane permeability |
|
• Erythropoietin:
|
• Triggers RBC production in presence of decreased
oxygenation |
|
• Clinical Manifestations of Altered Renal
Function • Lab: |
• Elevated creatinine level (specific to renal
function) • Decreased 24 hour creatinine clearance (normal is 90-139 ml/min for male and 80- 125 ml/min for women) • Electrolyte imbalances |
|
• Creatinine:
|
End product of muscle and protein
metabolism. Is a direct measure of renal function because muscle mass and metabolism is fairly constant • Men- 0.6-1.2 mg/dl • Females- 0.5/1.1 mg/dl |
|
BUN:
|
• Measure level of urea nitrogen and is an indirect
measure of renal elimination of urea. Nor specific to renal function |
|
• Stress Incontinence:
|
• Loss of urine during coughing, sneezing,
jogging or lifting. Results from weakening of the bladder neck supports and/or urethral sphincter weakness |
|
Urge incontinence:
|
• Involuntary loss of urine associated with a
sudden urge to void. Clients cannot suppress the signal relaxing the urethral sphincter |
|
• Reflex incontinence:
|
• Abnormal flexion of the detrusor muscles
causing bladder contraction and voiding • Associated with central nervous system lesions from stroke or spinal lesions from traumatic injury or CA |
|
• Overflow incontinence
|
• Involuntary loss of urine due to over
distension of the bladder. Often associated with a neurological problem causing a lack of the sensation that notifies the client of need to void. May also be associated with enlarge prostate, genital prolapse (in women) |
|
• Functional incontinence:
|
• Leakage of urine caused by factors other
than a disease of the lower urinary tract • Common cause is dementia, where the client is unable to interpret the need to urinate with a need to go to a bathroom facility (not go in public) |
|
• Cystitis:
|
• An inflammation of the bladder. Most commonly
caused by in infectious agent, 90% of which are E. Coli. The organisms first grow in the perineal area and then invade the urinary bladder. Most common cause of infection is poor hygiene. • Patho: Bacteria move up the urethra and into the bladder, resulting in an inflammatory response, elevation of white (See table 73-2, p. 1679) |
|
Urethritis:
|
• Inflammation of the urethra that results in
symptoms similar to the inflammatory symptoms of UTI. Common causes in men are STDs (gonorrhea) and non-specific urethritis. • In women the causes may be an STD or the same cause as cystitis • Patho: Bacteria enter the urethra and trigger inflammatory response, often resulting in whitish exudate from the meatus |
|
• Pyelonephritis:
|
• Infection or the effects of infection in the
kidney. • Acute pyelonephritis may result from an acute UTI with bacteria traveling up the ureters and into the kidney. Chronic pyelonephritis is the result of chronic or repeated infections of the kidney |
|
• Cystitis:
|
• Frequency, urgency, and dysuria
• Potentially: – Cloudy urine – Foul smelling urine – Blood in urine – Abdominal cramping |
|
• Urethritis
|
• Burning on urination
• Discharge from the penis, urethral meatus or vagina and/or lower abdominal discomfort. |
|
• Pyelonephritis:
|
• Flank pain, abdominal pain, low grade
fever |
|
• Possible complications
• Cystitis: |
• Scarring of the urinary bladder,
septicemia, urethral stricture from scarring, pyelonephritis |
|
• Possible complications
• Urethritis: |
• urethral stricture from scarring, cystitis,
pyelonephritis |
|
• Possible complications
• Pyelonephritis: • |
Septicemia
• Septic shock • Renal failure • Scarring of the renal system |
|
Retinopathy:
complication of diabetes |
Related to blockage of retinal
blood vessels and leakage, leading to retinal hypoxia. Occurs in almost 100% of type I by 20 years of disease progression and 78% of type II. Associated with fasting blood glucose levels >129 mg/dl. Accompanying hypertension increases the risk. |
|
Neuropathy:
Diabetic complication |
May be focal or
diffuse, and the most common are diffuse in nature. Hyperglycemia leads to neuropathy through blood vessel changes that lead to nerve tissue hypoxia and damage to both the axon and the myelin sheath. Excess glucose is converted to sorbitol which coats the nerve sheath interrupting nerve conduction. |
|
• Male Erectile Dysfunction:
Diabetic complication |
Occurs at a
higher rate and earlier in men with DM. Associated with a combination of neuropathy, vascular occlusions and other problems. Psychological factors can play a large part and cannot be overlooked. |
|
Leg and Foot complications:
Diabetic complication |
• Primarily result from the vascular occlusive side
effects and neuropathies associated with DM. Build up of plagues in the arterial circulation decreases cellular perfusion leading the tissue hypoxia and slow healing of wounds. This also increases risk for infection due to decreased availability of WBC’s and supportive proteins. |
|
• Integumentary problems
Diabetic complication |
are associate with
tissue hypoxia due to vascular occlusion. The resultant tissue weakness makes the system more susceptible to injury and delayed healing |
|
• Infections:
Diabetic complication |
As already noted tissue hypoxia
results in skin susceptibility to injury with delayed healing, lack of immune bodies to fight infection and decreased availability of nutrients to build new tissue |
|
Type I DM
|
only treatable by insulin
because there is no insulin production |
|
– Sulfonylureas
|
-Stimulate insulin production
|
|
– Meglitinides
|
-Stimulate insulin production
|
|
– Biguanides-
|
Decreases liver glucose release
and decreases cell resistance to insulin |
|
Alpha-Glucsidase inhibitors:
|
slow intestinal
digestion and absorption of CHO, reducing rate of glucose absorption |
|
• Thiazolidinedione agents:
|
enhance insulin
action, promoting glucose use in peripheral tissues |